Breaking News

Protalix in UPLYSO Supply Pact with Brazil

Will supply Gaucher drug and provide tech transfer to Fiocruz

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Protalix BioTherapeutics has entered into a supply and technology transfer agreement with Fundacao Oswaldo Cruz (Fiocruz), an arm of the Brazilian Ministry of Health, for UPLYSO (alfataliglicerase), the company’s enzyme replacement therapy for the treatment of Gaucher disease.   The tech transfer will take place during a seven-year term and will provide Fiocruz with the capacity and skills required for the Brazilian government to construct its own manufacturing facility to supply UPLYSO. F...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters